High doses of cytosine arabinoside (HD-Ara-C) as reinforcement during remission of acute myeloid leukemia.
High doses of Cytosine-arabinoside (Ara-C) (1 to 3gm/m2 every 12 hours during 48 hours) were administered monthly to 5 acute myeloid leukemia patients during complete remissions subsequent to relapses and reinduction treatment. Plasma Ara-C was measured using a radioimmunoassay and exhibited kinetics compatible with a bi- or tri- compartimental model. Tolerance was good, with mainly gastrointestinal toxicity and somnolence. The duration of remissions was relatively long, taking into account that these were second or third remissions.